Cardiol Therapeutics Inc. (CRDL)
NASDAQ: CRDL · Real-Time Price · USD
1.070
0.00 (0.00%)
Apr 25, 2025, 4:00 PM EDT - Market closed

Cardiol Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Market Capitalization
89105543211272
Upgrade
Market Cap Growth
93.06%93.06%67.34%-71.06%56.56%-21.55%
Upgrade
Enterprise Value
679424-169059
Upgrade
Last Close Price
1.081.280.840.511.852.18
Upgrade
PS Ratio
----1803.25-
Upgrade
PB Ratio
5.176.112.540.841.866.88
Upgrade
P/TBV Ratio
5.176.112.560.851.877.13
Upgrade
EV/Sales Ratio
----1441.08-
Upgrade
Debt / Equity Ratio
0.010.010.010.000.000.01
Upgrade
Asset Turnover
----0.00-
Upgrade
Quick Ratio
4.414.414.256.127.295.66
Upgrade
Current Ratio
4.524.524.366.277.545.94
Upgrade
Return on Equity (ROE)
-138.47%-138.47%-69.93%-48.16%-70.69%-147.74%
Upgrade
Return on Assets (ROA)
-73.43%-73.43%-37.71%-34.47%-46.58%-82.38%
Upgrade
Return on Capital (ROIC)
-94.44%-94.44%-46.14%-40.17%-53.83%-91.42%
Upgrade
Earnings Yield
-28.70%-24.30%-39.19%-70.37%-22.28%-22.60%
Upgrade
FCF Yield
-20.34%-16.61%-35.17%-62.10%-16.58%-10.04%
Upgrade
Buyback Yield / Dilution
-11.02%-11.02%-3.13%-44.61%-44.77%-15.63%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q